Search for: "Hatch v. State Bar" Results 161 - 180 of 183
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jan 2009, 2:06 am
That testimony killed the plaintiff's standard product liability case, because under California (and almost all other states') law, a plaintiff cannot establish causation in an inadequate warning case where the prescribing physician did not rely upon the allegedly defective warning. [read post]
9 Dec 2008, 12:15 pm
Application of the federal Hatch Act barring partisan political activities by certain State and municipal employeesJuan Molina-Crespo v United States Merit Systems Protection Board, USCA 6th Circuit, Docket No. 07-3745Juan Molina-Crespo served as the Executive Director of the Lorain County Children and Families First Council ("LCCFFC"), an Ohio government agency that is financed in part by the federal government. [read post]
3 Dec 2008, 5:19 pm
Roberts, Jr., as the Court was about to wind up its hearing on Philip Morris USA v. [read post]
1 Dec 2008, 9:27 pm
Bd. , No. 073745 In a claim for violation of the Hatch Act which prohibits state or local officer or employee from being a candidate for elective office, grant of summary judgment in favor of defendant-Merit Systems Protection Board is affirmed over claims that: 1) the district court erred in concluding that Board did not abuse its discretion in determining that plaintiff's violation of the Hatch Act, regulating the political activity of state employees who… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), The latest edition of US Trade Representative’s ‘Special 301 Report’: (Ars Technica), (Ars Technica), (IAM), (Intellectual Property Watch), (Patry Copyright Blog), (Managing Intellectual Property), (Patent Docs), (IP Law360), Court rejects RIAA ‘making available’ theory: Atlantic v Howell:… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
5 Feb 2008, 8:11 am
Abad, No. 06-0338 Conviction for armed robbery and murder is affirmed based on primary holding that defendant's claim under the Speedy Trial Act, 18 U.S.C. section 3162, is barred by the Act's waiver provision, and not subject to review for plain error under Federal Rule of Criminal Procedure 52(b). [read post]
14 Oct 2007, 7:52 pm
The court agreed stating: While the Supreme Court has characterized infringement as defined in the Hatch-Waxman Act as "highly artificial," see Eli Lilly & Co. v. [read post]